29.12.2016 20:01:55
|
Cempra Remains Sharply Lower After Early Sell-Off
(RTTNews) - After falling sharply in early trading, shares of Cempra (CEMP) continue to see substantial weakness in afternoon trading on Thursday. Cempra is currently down by 57 percent after hitting a record intraday low.
The steep drop by Cempra comes after the FDA rejected the pharmaceutical company's new drug applications for oral and intravenous solithromycin for the treatment of community-acquired bacterial pneumonia in adults.
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Cempra Holdings LLCmehr Nachrichten
Keine Nachrichten verfügbar. |